Abstract:Reactive crystallization to make cefixime trihydrate crystals via cefixime disodium reacting with hydrogen chloride was investigated using ATR FTIR and an online imaging instrument with the aim of developing an improved understanding of the operation and condition optimization and scale-up. The operation involves times of continuing introduction of aqueous HCl solution into a cefixime disodium solution in water and also periods at which HCl was stopped for breeding of crystals. The concentration profile of the reactant cefixime disodium monitored by ATR FTIR being almost constant in the first 30–40 min since the start of introduction of HCl suggests that cefixime disodium (cefixime2–) reacts with HCl to form cefixime sodium (cefixime1–) first, prior to the formation of solids. Online imaging, off-line SEM image analysis, and XRD analysis revealed that spherical amorphous solids were formed first; the solids were then aggregated, followed by phase transition on the surface of aggregates to well-shaped crystals. The causal relationship between the process conditions and the size, impurity content, crystallinity, and whiteness of the cefixime trihydrate crystals was also investigated. It was found that the solution pH value at the time at which introduction of the first portion of HCl solution was stopped to begin breeding crystals has a major impact on both the size and the whiteness of the crystals. High pH value favors smaller crystals with a sharp white appearance. The length of the crystal breeding time was found to be critical to the crystallinity. Explanation of the observed phenomena and an operational envelope were defined. The size distribution, whiteness, impurity content, and crystallinity of cefixime trihydrate crystals were satisfactory as long as the operation was kept within the defined envelope. The experiments were conducted on a 2 L reactor, then successfully scaled-up to 50 and 4000 L in industry after having considered the scale-up factor in stirrer rotation speed.

Process Analytical Technology (PAT) Aided Identification of Operational Spaces Leading to Tailored Crystal Size Distributions in Azithromycin Crystallization Via Coordinated Cooling and Solution Mediated Phase Transition

Optimization of Crystallization Process of Azithromycin Dihydrate

Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization

Improved Understanding of Cefixime Trihydrate Reactive Crystallization and Process Scale-up with the Aid of PAT

Process Intensification and Control Strategies in Cooling Crystallization: Crystal Size and Morphology Optimization of Α-Paba

Controlled Crystallization of Metastable Polymorphic Pharmaceutical: Comparative Study of Batchwise and Continuous Tubular Crystallizers

Online monitor of Aspirin crystallization process

Agglomeration Mechanism of Azithromycin Dihydrate in Acetone–Water Mixtures and Optimization of the Powder Properties

Analytical technology aided optimization and scale‐up of impinging jet mixer for reactive crystallization process

Optimization and Control of Crystal Shape and Size in Protein Crystallization Process

Combined Application of in Situ Fbrm, Atr-Ftir, and Raman on Polymorphism Transformation Monitoring During the Cooling Crystallization

Manipulation of Crystal Morphology of Zoxamide Based on Phase Diagram and Crystal Structure Analysis

Process analytical technology-based (PAT) model simulations of a combined cooling, seeded and antisolvent crystallization of an active pharmaceutical ingredient (API)

A High-Throughput System Combining Microfluidic Hydrogel Droplets with Deep Learning for Screening the Antisolvent-Crystallization Conditions of Active Pharmaceutical Ingredients

Real-Time Characterization of Crystal Shape and Size Distribution Based on Moving Window and 3D Imaging in a Stirred Tank

A Comprehensive Workflow towards More Equant‐Shaped Crystals of Active Pharmaceutical Ingredients

Spherulitic Growth Strategy for Agitation-Induced Formation of Spherical Amoxicillin Sodium Products

Tailoring the crystal size distribution of an active pharmaceutical ingredient by continuous antisolvent crystallization in a planar oscillatory flow crystallizer

Protein Nucleation and Crystallization Process with Process Analytical Technologies in a Batch Crystallizer

Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing

Automated Continuous Crystallization Platform with Real-Time Particle Size Analysis via Laser Diffraction